Professor, Internal Medicine, Oakland University Wm Beaumont SOM
Endocrinology
Dr. George Grunberger, MD
|
|
Give Review
George Grunberger is an expert in the field of Endocrinology. He went to NYU School of Medicine. He over the years received 1 awards: "Fellow (FACE)". George Grunberger is also a published doctor. He has 100 publication published. The most recent publication is: Alpha2-Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells. He accepts all Medicare patients.
Publications
- The traditions and risks of fasting for lipid profiles in patients with Diabetes.
- Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials.
- Insulin analogs-are they worth it? Yes!
- Consensus statement by the american association of clinical endocrinologists/american college of endocrinology insulin pump management task force.
- Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin.
- Novel Therapies for Management of Type 2 Diabetes Mellitus Part 1. Pramlintide and Bromocriptine-QR.
- The need for better insulin therapy.
- Novel Therapies for Management of Type 2 Diabetes Mellitus Part 2 - Addressing the incretin defect in clinical setting in 2013.
- Do we need a fasting Lipid profile to assess cardiovascular risk?
- Quo vadis nateglinide? Ten-year perspective.
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a Diabetes mellitus comprehensive care plan.
- American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a Diabetes mellitus comprehensive care plan: executive summary.
- Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.
- Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management.
- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 Diabetes mellitus: an algorithm for glyce...
- Diagnosis and management of preDiabetes in the continuum of hyperglycemia: when do the risks of Diabetes begin? A consensus statement from the American College of Endo...
- Road maps to achieve glycemic control in type 2 Diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.
- Abnormalities of vitamin D and Calcium metabolism after surgical treatment of morbid obesity: a study of 136 patients.
- The benefits of early intervention in obese diabetic patients With FBCx: a new dietary fibre.
- Fetuin-null mice are protected against obesity and insulin resistance associated With aging.
- Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 Diabetes.
- Diabetes care credit system: a model for comprehensive and optimal Diabetes care.
- The C-peptide signaling.
- Type 1 diabetic neuropathy and C-peptide.
- Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.
- Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in Diabetes.
- Proinsulin C-peptide--a consensus statement.
- Coronary vascular dysfunction in premenopausal women with Diabetes mellitus.
- Hippocampal neuronal apoptosis in type 1 Diabetes.
- Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene.
- Plasma alpha2-HS glycoprotein concentrations in patients With acute myocardial infarction quantified by a modified ELISA.
- --to: Charlton R, Smith G, Day A (2001) Munchausen''s syndrome manifesting as factitious hypoglycaemia. Diabetologia 44: 784-785.
- Molecular basis for the insulinomimetic effects of C-peptide.
- Genetic mapping and functional studies of a natural inhibitor of the insulin receptor tyrosine kinase: the mouse ortholog of human alpha2-HS glycoprotein.
- C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
- Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 Diabetes.
- C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts.
- Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts With the insulin receptor.
- The influence of treatment modality and ethnicity on attitudes in type 2 Diabetes.
- Cancer in a patient receiving IGF-I therapy.
- Effects of autonomic neuropathy on coronary blood flow in patients with Diabetes mellitus.
- Alpha2-Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells.
- The reliability of the Diabetes Care Profile for African Americans.
- The safety of injecting insulin through clothing.
- Differences in the impact of dietary restrictions on African Americans and Caucasians With NIDDM.
- Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase.
- Recombinant human alpha 2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway Without affecting metabolic signalling in Chinese hamster ovary cells overexpre...
- The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II Diabetes mellitus.
- Erythrocyte insulin and insulin-like growth factor-I receptor tyrosine kinase activity in hypertension in pregnancy.
- Diabetes and related metabolic risk factors among Arab Americans.
- Insulin versus glipizide treatment in patients with non-insulin-dependent Diabetes mellitus. Effects on blood pressure and glucose tolerance.
- Baculoviral expression of a natural inhibitor of the human insulin receptor tyrosine kinase.
- Inhibitors of the insulin receptor tyrosine kinase.
- Insulin induces tyrosine phosphorylation of a 90-kDa protein during postischemic brain reperfusion.
- Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level.
- Regulation of hepatic insulin receptor tyrosine kinase in rat models of mild insulin resistance.
- Continuous versus intermittent sulphonylurea therapy in non-insulin-dependent Diabetes mellitus.
- Potential role of growth factors in global brain ischemia and reperfusion. Observation of insulin-driven tyrosine phosphorylation of a 90-kDa protein during reperfusion.
- Insulin therapy, blood pressure, and NIDDM.
- Insulin and IGF1 receptor function among Type II diabetic responders and nonresponders to glyburide.
- Insulin resistance in a case of coexisting insulinoma and type 2 Diabetes.
- Functional characterization of insulin and IGF-I receptors in chicken lens epithelial and fiber cells.
- Maintenance of sulfonylurea responsiveness in NIDDM. Randomized double-blind study of intermittent glyburide therapy.
- Impaired translocation of protein kinase C activity in human non-insulin-dependent Diabetes mellitus.
- Diacylglycerols modulate insulin action in rat adipocytes.
- Usefulness of albumin-based and total protein-based fructosamine correction formulas in Diabetes practice.
- Interplay between insulin signalling and protein kinase C.
- Repeated pregnancy Without lactation: effects on maternal glycemic control, pregnancy outcome, carcass composition, and fat distribution in rats.
- Abnormal insulin receptor tyrosine kinase activity in kidney basolateral membranes from non-insulin-dependent diabetic rats.
- High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats.
- Diacylglycerols modulate phosphorylation of the insulin receptor from human mononuclear cells.
- Insulin antagonistic effects of insulin receptor antibodies on plasma membrane (Ca2+ + Mg2+) ATPase activity: a possible etiology of Type B insulin resistance.
- Effects of food restriction and insulin treatment on (Ca2+ + Mg2+)-ATPase response to insulin in kidney basolateral membranes of noninsulin-dependent diabetic rats.
- Receptor-mediated endocytosis of insulin: inhibition of [125I]iodoinsulin internalization in insulin resistant diabetic states of man.
- Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a Type A insulin-resista...
- Plasma membrane phosphoLipid content in non-insulin-dependent streptozotocin-diabetic rats--effect of insulin.
- Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up.
- [Fluorophotometry of the vitreous body in insulin-dependent Diabetes mellitus with minimal retinopathy or without it].
- Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II Diabetes.
- Posterior vitreous fluorophotometry in diabetic patients With minimal or no retinopathy.
- Receptors for insulin and growth hormone on lymphoid cells.
- Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Effects on binding and internalization.
- Glycosylation defects alter insulin but not insulin-like growth factor I binding to Chinese hamster ovary cells.
- Receptor-mediated endocytosis of polypeptide hormones is a regulated process: inhibition of [125I]iodoinsulin internalization in hypoinsulinemic Diabetes of rat and man.
- Immunological similarity between the insulin receptor and the protein encoded by the src oncogene.
- Insulin receptor of human cerebral gliomas. Structure and function.
- Impaired 6-phosphofructokinase activity in mononuclear leukocytes from patients with type II Diabetes mellitus.
- Structural difference of the insulin receptors from circulating monocytes and erythrocytes.
- Polypeptide hormone receptor phosphorylation: is there a role in receptor-mediated endocytosis of human growth hormone?
- Human circulating monocytes internalize 125I-insulin in a similar fashion to rat hepatocytes: relevance to receptor regulation in target and nontarget tissues.
- An alteration in apparent molecular weight of the insulin receptor from the human monocyte cell line U-937.
- Use of tyrosine-containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases.
- Structure of the insulin receptor and post-receptor events in cells from a Type A insulin-resistant patient with normal alpha-subunit but defective function of the bet...
- Tyrosine kinase activity of the insulin receptor of patients with Type A extreme insulin resistance: studies with circulating mononuclear cells and cultured lymphocytes.
- Tumor-promoting phorbol ester stimulates tyrosine phosphorylation in U-937 monocytes.
- Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient With normal insulin binding.
- Insulin-like growth factor-I (IGF-I) stimulates tyrosine kinase activity in purified receptors from a rat liver cell line.
- The insulin receptor of a human monocyte-like cell line: characterization and function.
- The insulin-stimulated receptor kinase is a tyrosine-specific casein kinase.
Schools
New York University School Of Medicine
University Hospital
National Institute Health
Procedures Preformed
- Continuous Glucose Monitoring
- Diet Counseling
- EKG (Electrocardiogram, ECG)
- Immunization
- View All
Conditions Treated
- Calcium Metabolism Disorders
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- View All
Doctors Specialties
- Diabetes Medicine
- Internal Medicine
- Metabolism Disorders
- Thyroid Disorders
- Endocrinology
Accepted Insurances
Awards
- Fellow (FACE)
Education
-
Case Western Reserve University - University Hospitals -
NYU School of Medicine
Drug Facts
| NPI NUMBER | 1477558450 | |
| NPPES Provider LastName | GRUNBERGER | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 483025054 | |
| NPPES Provider State | MI | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 2843.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477558450 |
| Last Name Of The Provider | GRUNBERGER |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
Dr. Carl E. Palffy, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Cecilia C. Cosma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Faiz Mansour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Waseem Alam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clarence McRipley Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suraj P. Nighoon, MD |
|
Dr. Anjana Myneni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Bradlee, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Subha L. Gulati |